These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. HORMONAL THERAPY OF METASTATIC FEMALE BREAST CARCINOMA. V. PHENOL,4,4'-(DL-1,2-DIETHYL-ETHYLENE)DI- AND ANDROST-4-EN-3-ONE, 9-CHLORO-11-BETA, 17-BETA-DIHYDROXY-17-METHYL-. GOLDENBERG IS; HAYES MA; MORIN JE Cancer; 1965 Apr; 18():447-9. PubMed ID: 14278041 [No Abstract] [Full Text] [Related]
6. A STUDY OF THE URINARY PORPHYRINS AND PORPHYRIN PRECURSORS IN PATIENTS WITH MALIGNANT DISEASE RECEIVING DIETHYLSTILBESTROL. THEOLOGIDES A; KENNEDY BJ; WATSON CJ Metabolism; 1964 May; 13():391-5. PubMed ID: 14169217 [No Abstract] [Full Text] [Related]
7. DELALUTIN AND ESTROGENS FOR THE TREATMENT OF ADVANCED MAMMARY CARCINOMA IN THE POSTMENOPAUSAL WOMAN. CROWLEY LG; MACDONALD I Cancer; 1965 Apr; 18():436-46. PubMed ID: 14278040 [No Abstract] [Full Text] [Related]
8. DIETHYLSTILBESTROL (NSC-3070) AND TESTOSTERONE PROPIONATE (NSC-9166) THERAPY IN ADVANCED BREAST CANCER. 1. A COMPARISON. KENNEDY BJ; THEOLOGIDES A; FORTUNY I; FOLET J; BROWN J Cancer Chemother Rep; 1964 Sep; 41():11-4. PubMed ID: 14213133 [No Abstract] [Full Text] [Related]
9. THE ENDOCRINE TREATMENT OF METASTATIC BREAST CANCER. HORTLING H Geriatrics; 1965 Jan; 20():51-60. PubMed ID: 14249988 [No Abstract] [Full Text] [Related]
10. [Value of cyto-hormonal smears in the conduct of androgenic treatment of women with breast cancer]. Marsan C; Sicard A Presse Med (1893); 1969 Dec; 77(54):2033-6. PubMed ID: 5378459 [No Abstract] [Full Text] [Related]
11. ENDOCRINE TREATMENT OF BREAST CANCER. NISSEN-MEYER R Acta Unio Int Contra Cancrum; 1964; 20():531-4. PubMed ID: 14151981 [No Abstract] [Full Text] [Related]
12. Hormonal treatment of hypercalcemia caused by bone metastases. Muirhead W Can Med Assoc J; 1967 Sep; 97(11):569-72. PubMed ID: 6050889 [No Abstract] [Full Text] [Related]
13. Comparison of methotrexate (NSC-740) and testosterone propionate (NSC-9166) in the treatment of breast cancer. Nevinny HB; Hall TC; Haines C; Krant MJ J Clin Pharmacol J New Drugs; 1968; 8(2):126-9. PubMed ID: 5240363 [No Abstract] [Full Text] [Related]
15. SURVIVAL OF WOMEN WITH HORMONALLY TREATED BREAST CANCER. GOLDENBERG IS; BAILAR JC; LOWRY R Surg Gynecol Obstet; 1964 Oct; 119():785-9. PubMed ID: 14211212 [No Abstract] [Full Text] [Related]
16. Androgens in breast cancer. III. Breast cancer recurrences years after mastectomy and increased androgenic activity. Grattarola R; Secreto G; Recchione C Am J Obstet Gynecol; 1975 Jan; 121(2):169-72. PubMed ID: 1115123 [TBL] [Abstract][Full Text] [Related]
17. RADIOACTIVE PHOSPHORUS TREATMENT OF BONE-METASTATIC CARCINOMA OF THE PROSTATE. SMART JG Lancet; 1964 Oct; 2(7365):882-3. PubMed ID: 14197184 [No Abstract] [Full Text] [Related]
18. COMPARATIVE STUDY OF 6-DEHYDRO-17ALPHA-METHYLTESTOSTERONE AND TESTOSTERONE PROPIONATE IN HUMAN BREAST CANCER. NEVINNY-STICKEL HB; DEDERICK MM; HAINES CR; HALL TC Cancer; 1964 Jan; 17():95-9. PubMed ID: 14102076 [No Abstract] [Full Text] [Related]
19. [THERAPEUTICS OF ADVANCED CANCER OF THE BREAST]. MARINGORRIZ FJ; SOLSONA F; CASTILLORAMIREZ A Clin Lab (Zaragoza); 1964 Mar; 77():175-88. PubMed ID: 14157950 [No Abstract] [Full Text] [Related]
20. [ON SOME FEATURES OF THE COURSE OF METASTASIS OF BREAST CANCER INTO THE SKELETON UNDER THE INFLUENCE OF COMBINED RADIOTHERAPY AND HORMONE THERAPY]. TAGER IL; NIVINSKAIA MM Med Radiol (Mosk); 1964 Jan; 9():12-9. PubMed ID: 14176493 [No Abstract] [Full Text] [Related] [Next] [New Search]